Package 42858-502-03

Brand: buprenorphine

Generic: buprenorphine
NDC Package

Package Facts

Identity

Package NDC 42858-502-03
Digits Only 4285850203
Product NDC 42858-502
Product ID 42858-502_db126900-5151-4563-9e39-55caaeada4ea
Description

30 TABLET in 1 BOTTLE (42858-502-03)

Marketing

Marketing Status
Marketed Since 2017-10-25
Brand buprenorphine
Generic buprenorphine
Sample Package No

Linked Drug Pages (1)

BUPRENORPHINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBLINGUAL"], "spl_id": "db126900-5151-4563-9e39-55caaeada4ea", "openfda": {"upc": ["0342858501033", "0342858502030"], "unii": ["56W8MW3EN1"], "rxcui": ["351264", "351265"], "spl_set_id": ["da90618a-5621-4b15-bc48-9dcc631418de"], "manufacturer_name": ["Rhodes Pharmaceuticals L.P."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (42858-502-03)", "package_ndc": "42858-502-03", "marketing_start_date": "20171025"}], "brand_name": "BUPRENORPHINE", "product_id": "42858-502_db126900-5151-4563-9e39-55caaeada4ea", "dosage_form": "TABLET", "pharm_class": ["Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "42858-502", "dea_schedule": "CIII", "generic_name": "BUPRENORPHINE", "labeler_name": "Rhodes Pharmaceuticals L.P.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPRENORPHINE", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}], "application_number": "ANDA207276", "marketing_category": "ANDA", "marketing_start_date": "20171025", "listing_expiration_date": "20271231"}